Chitotriosidase Activity and Gene Polymorphism in Iranian Patients with Gaucher Disease and Sibling Carriers
- PMID: 27843468
- PMCID: PMC5100039
Chitotriosidase Activity and Gene Polymorphism in Iranian Patients with Gaucher Disease and Sibling Carriers
Abstract
Objective: Chitotriosidase (CT) activity is a useful biomarker for diagnosis and monitoring of Gaucher disease (GD). Its application is limited by some variants in the CT gene. Two main polymorphisms are 24 bp duplication and G102S led to reduce CT activity. The aim of this study was to determine these variants influencing on plasma CT activity.
Materials & methods: Blood samples were collected from 33 patients with GD, 15 sibling carriers and 105 healthy individuals serving as controls. CT activity was measured using 4-methylumbelliferyl-β-D-N,N',N″triacetylchitotrioside substrate in plasma samples. The CT genotypes of 24 bp duplication and G102S variants were determined using PCR and PCR-RFLP.
Results: Untreated GD patients had a significantly higher CT activity compared to treated patients (P = 0.021). In addition, chitotriosidase activity in carriers was higher rather than controls. Allele frequencies of 24 bp duplication in GD patients, sibling carriers and controls were 0.21, 0.266 and 0.29 and for G102S were 0.318, 0.366 and 0.219, respectively. Different G102S genotypes had not significant effect on CT activity. Chitotriosidase activity has a positive correlation with age in normal group, carriers, and negative correlation with hemoglobin in GD patients. Using cut-off level of 80.75 nmol/ml/h, sensitivity and specificity of CT activity were 93.9% and 100%, respectively.
Conclusion: Chitotriosidase activity is a suitable biomarker for diagnosis and monitoring of GD. Determination of 24 bp duplication is helpful for more accurate monitoring the GD patient's therapy. However, it seems that, specifying of the G102S polymorphism is not required for Iranian GD patients.
Keywords: 24 bp Duplication; Chitotriosidase; Gaucher Disease; PCR-RFLP; Polymorphism.
Figures
Similar articles
-
Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoring.Clin Biochem. 2013 Dec;46(18):1804-7. doi: 10.1016/j.clinbiochem.2013.09.006. Epub 2013 Sep 20. Clin Biochem. 2013. PMID: 24060732
-
[Comparison and clinical application of two methods for determination of plasma chitotriosidase activity].Zhonghua Er Ke Za Zhi. 2012 Nov;50(11):834-8. Zhonghua Er Ke Za Zhi. 2012. PMID: 23302614 Chinese.
-
Chitotriosidase genotype and plasma activity in patients type 1 Gaucher's disease and their relatives (carriers and non carriers).Haematologica. 2001 Sep;86(9):977-84. Haematologica. 2001. PMID: 11532627
-
Accuracy of chitotriosidase activity and CCL18 concentration in assessing type I Gaucher disease severity. A systematic review with meta-analysis of individual participant data.Haematologica. 2021 Feb 1;106(2):437-445. doi: 10.3324/haematol.2019.236083. Haematologica. 2021. PMID: 32001533 Free PMC article.
-
Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases.Acta Paediatr Suppl. 2005 Mar;94(447):43-6; discussion 37-8. doi: 10.1111/j.1651-2227.2005.tb02110.x. Acta Paediatr Suppl. 2005. PMID: 15895711 Review.
Cited by
-
Diagnostic methods for Lysosomal Storage Disease.Rep Biochem Mol Biol. 2019 Jan;7(2):119-128. Rep Biochem Mol Biol. 2019. PMID: 30805390 Free PMC article.
References
-
- Bennett LL, Mohan D. Gaucher disease and its treatment options. Ann Pharmacother. 2013;47(9):1182–93. - PubMed
-
- Shrestha B, Devgan A, Sharma M. Gaucher’s disease: rare presentation of a rare disease. J Child Neurol. 2013;28(10):1296–8. - PubMed
-
- Adly AA, Ismail EA, Ibraheem TM. Macrophagederived soluble CD163 level in young patients with Gaucher disease: relation to phenotypes, disease severity and complications. Int Immunopharmacol. 2015;24(2):416–22. - PubMed
-
- Irún P, Alfonso P, Aznarez S, Giraldo P, Pocovi M. Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoring. Clin Biochem. 2013;46(18):1804–7. - PubMed
LinkOut - more resources
Full Text Sources